Meijerman I[au] - Search Results

Year	Number of Results
1996	1
1997	1
1999	4
2001	1
2003	1
2004	2
2005	3
2006	7
2007	4
2008	3
2009	2
2010	2
2011	2
2012	3
2013	7
2014	3
2015	1
2017	1
2021	1
2023	1
2024	1

1

Implementation of Competency-Based Pharmacy Education (CBPE).

Koster A, Schalekamp T, Meijerman I. Koster A, et al. Among authors: meijerman i. Pharmacy (Basel). 2017 Feb 21;5(1):10. doi: 10.3390/pharmacy5010010. Pharmacy (Basel). 2017. PMID: 28970422 Free PMC article. Review.

2

Relevance of in vitro and clinical data for predicting CYP3A4-mediated herb-drug interactions in cancer patients.

Goey AK, Mooiman KD, Beijnen JH, Schellens JH, Meijerman I. Goey AK, et al. Among authors: meijerman i. Cancer Treat Rev. 2013 Nov;39(7):773-83. doi: 10.1016/j.ctrv.2012.12.008. Epub 2013 Feb 8. Cancer Treat Rev. 2013. PMID: 23394826 Review.

3

Pharmacogenetic screening of the gene deletion and duplications of CYP2D6.

Meijerman I, Sanderson LM, Smits PH, Beijnen JH, Schellens JH. Meijerman I, et al. Drug Metab Rev. 2007;39(1):45-60. doi: 10.1080/03602530600952206. Drug Metab Rev. 2007. PMID: 17364880 Review.

4

Induction of apoptosis and changes in nuclear G-actin are mediated by different pathways: the effect of inhibitors of protein and RNA synthesis in isolated rat hepatocytes.

Meijerman I, Blom WM, de Bont HJ, Mulder GJ, Nagelkerke JF. Meijerman I, et al. Toxicol Appl Pharmacol. 1999 Apr 1;156(1):46-55. doi: 10.1006/taap.1998.8616. Toxicol Appl Pharmacol. 1999. PMID: 10101098

5

Herb-drug interactions in oncology: focus on mechanisms of induction.

Meijerman I, Beijnen JH, Schellens JH. Meijerman I, et al. Oncologist. 2006 Jul-Aug;11(7):742-52. doi: 10.1634/theoncologist.11-7-742. Oncologist. 2006. PMID: 16880233 Free article. Review.

6

An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons.

Brandon EF, Raap CD, Meijerman I, Beijnen JH, Schellens JH. Brandon EF, et al. Among authors: meijerman i. Toxicol Appl Pharmacol. 2003 Jun 15;189(3):233-46. doi: 10.1016/s0041-008x(03)00128-5. Toxicol Appl Pharmacol. 2003. PMID: 12791308 Review.

7

The role of nuclear receptors in pharmacokinetic drug-drug interactions in oncology.

Harmsen S, Meijerman I, Beijnen JH, Schellens JH. Harmsen S, et al. Among authors: meijerman i. Cancer Treat Rev. 2007 Jun;33(4):369-80. doi: 10.1016/j.ctrv.2007.02.003. Epub 2007 Apr 23. Cancer Treat Rev. 2007. PMID: 17451886 Review.

8

Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer.

Bosch TM, Meijerman I, Beijnen JH, Schellens JH. Bosch TM, et al. Among authors: meijerman i. Clin Pharmacokinet. 2006;45(3):253-85. doi: 10.2165/00003088-200645030-00003. Clin Pharmacokinet. 2006. PMID: 16509759 Review.

9

Combined action and regulation of phase II enzymes and multidrug resistance proteins in multidrug resistance in cancer.

Meijerman I, Beijnen JH, Schellens JH. Meijerman I, et al. Cancer Treat Rev. 2008 Oct;34(6):505-20. doi: 10.1016/j.ctrv.2008.03.002. Epub 2008 Apr 14. Cancer Treat Rev. 2008. PMID: 18413281 Review.

10

The effect of Echinacea purpurea on the pharmacokinetics of docetaxel.

Goey AK, Meijerman I, Rosing H, Burgers JA, Mergui-Roelvink M, Keessen M, Marchetti S, Beijnen JH, Schellens JH. Goey AK, et al. Among authors: meijerman i. Br J Clin Pharmacol. 2013 Sep;76(3):467-74. doi: 10.1111/bcp.12159. Br J Clin Pharmacol. 2013. PMID: 23701184 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

45 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year